Evidence and speculations: vaccines and therapeutic options for COVID-19 pandemic

Hum Vaccin Immunother. 2021 Apr 3;17(4):1113-1121. doi: 10.1080/21645515.2020.1824497. Epub 2020 Oct 16.

Abstract

A novel coronavirus (2019-nCov) emerged in China, at the end of December 2019 which posed an International Public Health Emergency, and later declared as a global pandemic by the World Health Organization (WHO). The International Committee on Taxonomy of Viruses (ICTV) named it SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2), while the disease was named COVID-19 (Coronavirus Disease- 2019). Many questions related to the exact mode of transmission, animal origins, and antiviral therapeutics are not clear yet. Nevertheless, it is required to urgently launch a new protocol to evaluate the side effects of unapproved vaccines and antiviral therapeutics to accelerate the clinical application of new drugs. In this review, we highlight the most salient characteristics and recent findings of COVID-19 disease, molecular virology, interspecies mechanisms, and health consequences related to this disease.

Keywords: SARS-CoV-2; covid-19; genome; human health; therapeutic options; vaccine development.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / pharmacology
  • Alanine / analogs & derivatives
  • Alanine / pharmacology
  • Animals
  • Antiviral Agents / adverse effects
  • Antiviral Agents / pharmacology*
  • COVID-19 / pathology*
  • COVID-19 / prevention & control
  • COVID-19 / transmission*
  • COVID-19 Drug Treatment
  • COVID-19 Vaccines / adverse effects
  • COVID-19 Vaccines / immunology*
  • Chiroptera / virology
  • Coronavirus Protease Inhibitors / pharmacology*
  • Humans
  • Lopinavir / pharmacology
  • Ritonavir / pharmacology
  • SARS-CoV-2 / drug effects
  • Virus Attachment
  • Virus Internalization

Substances

  • Antiviral Agents
  • COVID-19 Vaccines
  • Coronavirus Protease Inhibitors
  • Lopinavir
  • remdesivir
  • Adenosine Monophosphate
  • Ritonavir
  • Alanine

Grants and funding

China Postdoctoral Science Foundation Grant (2020M672291) for Suliman Khan.